Pirmax-200 Tablets contain Pirfenidone 200 mg, an antifibrotic medicine indicated for the treatment of Idiopathic Pulmonary Fibrosis (IPF) in adults. Pirfenidone helps slow the progression of lung scarring (fibrosis), supporting the preservation of lung function and improving disease management when taken as prescribed.
Key Benefits
- Helps slow the progression of Idiopathic Pulmonary Fibrosis (IPF)
- Supports the preservation of lung function
- Reduces the rate of lung tissue scarring
- Contributes to improved long-term disease management
- Oral tablet formulation for convenient administration
Active Ingredient
- Pirfenidone IP 200 mg
Indications
Pirmax-200 Tablets are indicated for:
- Treatment of Idiopathic Pulmonary Fibrosis (IPF) in adults
- Management of progressive fibrotic lung disease as prescribed by a healthcare professional
